Merck & Co Inc (MRK)
101.87
-0.01
(-0.01%)
USD |
NYSE |
Nov 04, 16:00
101.68
-0.19
(-0.19%)
Pre-Market: 08:39
Merck Cash from Operations (Quarterly): 5.637B for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.637B |
| March 31, 2024 | 3.09B |
| December 31, 2023 | 246.00M |
| September 30, 2023 | 7.717B |
| June 30, 2023 | 3.704B |
| March 31, 2023 | 1.339B |
| December 31, 2022 | 4.43B |
| September 30, 2022 | 5.602B |
| June 30, 2022 | 4.302B |
| March 31, 2022 | 4.761B |
| December 31, 2021 | 5.031B |
| September 30, 2021 | 4.797B |
| June 30, 2021 | 2.49B |
| March 31, 2021 | 1.791B |
| December 31, 2020 | 4.006B |
| September 30, 2020 | 2.173B |
| June 30, 2020 | 3.367B |
| March 31, 2020 | 707.00M |
| December 31, 2019 | 4.794B |
| September 30, 2019 | 4.226B |
| June 30, 2019 | 3.084B |
| March 31, 2019 | 1.336B |
| December 31, 2018 | 3.592B |
| September 30, 2018 | 2.793B |
| June 30, 2018 | 3.382B |
| Date | Value |
|---|---|
| March 31, 2018 | 1.155B |
| December 31, 2017 | 4.019B |
| September 30, 2017 | -1.171B |
| June 30, 2017 | 3.317B |
| March 31, 2017 | 286.00M |
| December 31, 2016 | 3.632B |
| September 30, 2016 | 2.971B |
| June 30, 2016 | 1.60B |
| March 31, 2016 | 2.173B |
| December 31, 2015 | 4.246B |
| September 30, 2015 | 3.311B |
| June 30, 2015 | 2.697B |
| March 31, 2015 | 2.284B |
| December 31, 2014 | -1.035B |
| September 30, 2014 | 4.348B |
| June 30, 2014 | 2.315B |
| March 31, 2014 | 2.361B |
| December 31, 2013 | 3.026B |
| September 30, 2013 | 3.949B |
| June 30, 2013 | 2.338B |
| March 31, 2013 | 2.341B |
| December 31, 2012 | 1.809B |
| September 30, 2012 | 3.139B |
| June 30, 2012 | 2.92B |
| March 31, 2012 | 2.154B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
246.00M
Minimum
Dec 2023
7.717B
Maximum
Sep 2023
3.683B
Average
4.006B
Median
Dec 2020
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 3.571B |
| Johnson & Johnson | 7.993B |
| Eli Lilly and Co | 3.712B |
| Pfizer Inc | -1.781B |
| Moderna Inc | -1.274B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.069B |
| Cash from Financing (Quarterly) | 1.216B |
| Free Cash Flow | 13.15B |
| Free Cash Flow Per Share (Quarterly) | 1.905 |
| Free Cash Flow to Equity (Quarterly) | 1.277B |
| Free Cash Flow to Firm (Quarterly) | 5.065B |
| Free Cash Flow Yield | 5.08% |